You just read:

Tioga Pharmaceuticals Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome

News provided by

Tioga Pharmaceuticals, Inc.

Apr 12, 2012, 11:13 ET